Notice of Shareholding
25 Janeiro 2008 - 7:27AM
UK Regulatory
RNS Number:5399M
Arana Therapeutics Limited
25 January 2008
For Immediate Release 25 January 2008
Arana Therapeutics Limited
Notification of Shareholding
Arana Therapeutics Limited, (AIM: AAHx ASX: AAH) (the "Company"), the Australian
biopharmaceutical company that uses superior technology to develop next
generation drugs that will improve the lives of patients with inflammatory
diseases and cancer has identified on 24 January 2008 that with effect from 23
January 2008, Rockwell Securities Limited increased its holding by 6,673,116
ordinary shares to 18,361,279 (7.8% of the issued share capital of the Company)
ordinary shares in the capital of the Company.
For further information, please contact:
Arana Therapeutics Limited
Dr John Chiplin, Chief Executive Officer +61 (0)2 8061 9900
Niall Henderson, Chief Financial Officer +61 (0)2 8061 9900
Buchanan Communication
Lisa Baderoon/Rebecca Skye Dietrich +44 (0)20 7466 5000
Nomura Code Securities
Charles Walker +44 (0)20 7776 1206
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBAMLTMMTTMAP
Arana Therap. (LSE:AAHX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Arana Therap. (LSE:AAHX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Arana Therap. da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Arana Therapeutics